Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 5:28 PM
Ignite Modification Date:
2025-12-24 @ 5:28 PM
NCT ID:
NCT04413968
Eligibility Criteria:
Inclusion Criteria:
Population 1 :
* Children of priority staff welcomed in the crèche during the period of confinement, i.e. from 15 March to 9 May, regardless of the length of time they are in the crèche during this period and their "symptomatic or not" status during this period or on the day of inclusion.
* Consent of the holders of parental authority
* Affiliated to a social security system or entitled person
Population 2 :
* Nursery staff, regardless of their status/occupation and having had contact with the children during the period of confinement regardless of how long they have been in the nursery during this period and their "symptomatic or not" status during this period or on the day of inclusion.
* Consent to participate
* Affiliated to a social security system or entitled person
Population 3 :
* Hospital staff not exposed to patients and/or children, with or without children in day care, working in the bacteriology, biochemistry and biological haematology laboratories or in an administrative department of the participating hospitals.
* Affiliated to a social security system or entitled person
Exclusion Criteria:
Population 1 :
* Refusal to sign consent by parents
* Clinical condition requiring urgent medical assessment (attending physician or transfer to paediatric emergency)
Population 2 and 3 :
* Refusal to sign consent for staff
* Clinical condition requiring urgent medical evaluation
Healthy Volunteers:
True
Sex:
ALL
Minimum Age:
1 Month
Study:
NCT04413968
Study Brief:
Protocol Section:
NCT04413968